Shares in the company last traded at $0.51, or double the price compared to the February this year.
The halt will remain in place until the opening of trade on Tuesday 18th October 2016, or earlier if an announcement is made to the market.
Paradigm Biopharmaceuticals heads to market
Paradigm Biopharmaceuticals Ltd (ASX:PAR) has been granted a trading halt by the ASX this morning, pending details of a capital raising.